Device Endotherapy

Single Use Suction Valve (Sterile)

Payments companies reported to CMS as associated with Single Use Suction Valve (Sterile). "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$566Kassociated payments (2023-2025)
187clinicians with associated payments
2companies reporting

By year

2023 $327K
2024 $193K
2025 $46K

Payments reported as associated with Single Use Suction Valve (Sterile), per program year, as reported to CMS.

Who makes it

Specialties most often involved

Pulmonary Disease $474K
Critical Care Medicine (Internal Medicine) $46K
Urology $15K
Internal Medicine $15K
Thoracic Surgery (Cardiothoracic Vascular Surgery) $5,160
Pediatric Pulmonology $4,527

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Single Use Suction Valve (Sterile)

These are the largest totals companies reported as associated with Single Use Suction Valve (Sterile). They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Alexander Chen Saint Louis, MO Pulmonary Disease $130,802.16
Angela Argento Baltimore, MD Pulmonary Disease $71,611.96
Momen Wahidi Chicago, IL Pulmonary Disease $56,693.95
Hans Lee Baltimore, MD Pulmonary Disease $56,260.93
Shawn Nishi Galveston, TX Pulmonary Disease $38,822.56
Michael Machuzak Cleveland, OH Pulmonary Disease $28,306.74
Robert Kruklitis Allentown, PA Critical Care Medicine (Internal Medicine) $28,122.75
Alan Bickel Vancouver, WA Urology $15,306.40
Elliot Ho Loma Linda, CA Pulmonary Disease $8,730.57
Devin Sherman Franklin, TN Internal Medicine $3,680.00

Prescribed Single Use Suction Valve (Sterile)?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.